7th RSC-BMCS / DMDG New Perspectives in DMPK and Medicinal Chemistry

CEO and Company Director

Matt has a Master of Science in Computation from the University of Oxford and a PhD in Theoretical Physics from the University of Cambridge.

As Associate Director at Camitro (UK), ArQule Inc. and then Inpharmatica, he led a team developing predictive ADME models and state-of-the-art intuitive decision-support and visualization tools for drug discovery.

In January 2006, he became responsible for management of Inpharmatica’s ADME business, including experimental ADME services and the StarDrop software platform.

Following acquisition of Inpharmatica, Matt became Senior Director responsible for BioFocus DPI’s ADMET division and in 2009 led a management buyout of the StarDrop business to found Optibrium.

Linkedin

Account Manager 

Lauren brings over a decade of experience in customer engagement, account management and business development to her role at Optibrium. 

Before joining Optibrium, Lauren held commercial roles at Oracle and Cytel, where she partnered with healthcare organisations, biotech, and pharmaceutical companies to deliver tech & software solutions. She also gained extensive experience in the CRO sector with Quanticate, supporting global pharmaceutical and biotechnology clients across Europe and beyond. 

At Optibrium, Lauren is dedicated to building trusted relationships with customers, ensuring their continued success, and helping them to maximise the value of Optibrium’s software in accelerating drug discovery. With a strong background spanning clinical research, and enterprise technology, she combines commercial expertise with a genuine passion for supporting scientific innovation. 

Linkedin